For the quarter ending 2025-09-30, RYTM has $506,874K in assets. $211,191K in debts. $52,078K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 52,078 | 135,586 | ||
| Short-term investments | 363,974 | 155,444 | ||
| Accounts receivable, net | 33,034 | 26,122 | ||
| Inventory | 22,107 | 18,872 | ||
| Prepaid expenses and other current assets | 23,609 | 24,656 | ||
| Total current assets | 494,802 | 360,680 | ||
| Property and equipment, net | 237 | 297 | ||
| Right-of-use asset | 3,158 | 3,262 | ||
| Intangible assets, net | 5,533 | 5,747 | ||
| Restricted cash | 671 | 527 | ||
| Other long-term assets | 2,473 | 2,220 | ||
| Total assets | 506,874 | 372,733 | ||
| Accounts payable | 13,631 | 15,982 | ||
| Accrued expenses and other current liabilities | 84,456 | 69,185 | ||
| Other current liability - lg chem | - | 40,000 | ||
| Lease liability | 624 | 510 | ||
| Deferred royalty obligation, current | 5,556 | 3,778 | ||
| Total current liabilities | 104,267 | 129,455 | ||
| Deferred royalty obligation | 103,409 | 106,014 | ||
| Lease liability, non-current | 3,515 | 3,681 | ||
| Total liabilities | 211,191 | 239,150 | ||
| Series a convertible preferred stock, 0.001 par value 150,000 shares authorized 150,000 and 150,000 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively. liquidation preference of 150,000 as of september 30, 2025 | 146,866 | 145,491 | ||
| Common stock, 0.001 par value 120,000,000 shares authorized 66,684,077 and 62,390,654 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 67 | 64 | ||
| Additional paid-in capital | 1,454,048 | 1,241,744 | ||
| Accumulated other comprehensive (loss) | -926 | -2,248 | ||
| Accumulated deficit | -1,304,372 | -1,251,468 | ||
| Total stockholders' equity | 148,817 | -11,908 | ||
| Total liabilities, convertible preferred stock and stockholders' equity | 506,874 | 372,733 | ||
RHYTHM PHARMACEUTICALS, INC. (RYTM)
RHYTHM PHARMACEUTICALS, INC. (RYTM)